These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 30187864)

  • 61. Adapalene 0.1% and benzoyl peroxide 2.5% as a fixed-dose combination gel is as well tolerated as the individual components alone in terms of cumulative irritancy.
    Loesche C; Pernin C; Poncet M
    Eur J Dermatol; 2008; 18(5):524-6. PubMed ID: 18693154
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A 3-step acne system containing solubilized benzoyl peroxide versus clindamycin-benzoyl peroxide.
    Thiboutot D; Eichenfield L; Shalita A; Del Rosso JQ; Swinyer L; Tanghetti E; Tschen E; Parr L
    Cutis; 2009 Jul; 84(1):48-55. PubMed ID: 19743725
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Short-term combination therapy and long-term relapse prevention in the treatment of severe acne vulgaris.
    Tan J; Stein Gold L; Schlessinger J; Brodell R; Jones T; Cruz A; Kerrouche N; Jarratt M
    J Drugs Dermatol; 2012 Feb; 11(2):174-80. PubMed ID: 22270198
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A treatment for severe nodular acne: a randomized investigator-blinded, controlled, noninferiority trial comparing fixed-dose adapalene/benzoyl peroxide plus doxycycline vs. oral isotretinoin.
    Tan J; Humphrey S; Vender R; Barankin B; Gooderham M; Kerrouche N; Audibert F; Lynde C;
    Br J Dermatol; 2014 Dec; 171(6):1508-16. PubMed ID: 24934963
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Benzoyl peroxide, adapalene, and their combination in the treatment of acne vulgaris.
    Korkut C; Piskin S
    J Dermatol; 2005 Mar; 32(3):169-73. PubMed ID: 15863861
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Prevention and Reduction of Atrophic Acne Scars with Adapalene 0.3%/Benzoyl Peroxide 2.5% Gel in Subjects with Moderate or Severe Facial Acne: Results of a 6-Month Randomized, Vehicle-Controlled Trial Using Intra-Individual Comparison.
    Dréno B; Bissonnette R; Gagné-Henley A; Barankin B; Lynde C; Kerrouche N; Tan J
    Am J Clin Dermatol; 2018 Apr; 19(2):275-286. PubMed ID: 29549588
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Efficacy and tolerability of fixed-combination acne treatment in adolescents.
    Gold LS
    Cutis; 2013 Mar; 91(3):152-9. PubMed ID: 23617089
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Codelivery of benzoyl peroxide & adapalene using modified liposomal gel for improved acne therapy.
    Jain S; Kale DP; Swami R; Katiyar SS
    Nanomedicine (Lond); 2018 Jun; 13(12):1481-1493. PubMed ID: 29972675
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Efficacy of the addition of salicylic acid to clindamycin and benzoyl peroxide combination for acne vulgaris.
    Akarsu S; Fetil E; Yücel F; Gül E; Güneş AT
    J Dermatol; 2012 May; 39(5):433-8. PubMed ID: 22035285
    [TBL] [Abstract][Full Text] [Related]  

  • 70. A dermocosmetic regimen is able to mitigate skin sensitivity induced by a retinoid-based fixed combination treatment for acne: Results of a randomized clinical trial.
    Khammari A; Kerob D; Demessant AL; Nioré M; Dréno B
    J Cosmet Dermatol; 2024 Apr; 23(4):1313-1319. PubMed ID: 38102855
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A double-blind, randomized, bilateral comparison of skin irritancy following application of the combination acne products clindamycin/tretinoin and benzoyl peroxide/adapalene.
    Goreshi R; Samrao A; Ehst BD
    J Drugs Dermatol; 2012 Dec; 11(12):1422-6. PubMed ID: 23377511
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Solubilized benzoyl peroxide versus benzoyl peroxide/clindamycin in the treatment of moderate acne.
    Tanghetti E; Kircik L; Wilson D; Dhawan S
    J Drugs Dermatol; 2008 Jun; 7(6):534-8. PubMed ID: 18561583
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Treatment of Moderate Acne Vulgaris in Fitzpatrick Skin Type V or VI: Efficacy and Tolerability of Fixed Combination Clindamycin Phosphate 1.2%/Benzoyl Peroxide 3.75% Gel.
    Amar L; Kircik LH
    J Drugs Dermatol; 2018 Oct; 17(10):1107-1112. PubMed ID: 30365592
    [TBL] [Abstract][Full Text] [Related]  

  • 74. A fixed-dose combination of adapalene 0.1%-BPO 2.5% allows an early and sustained improvement in quality of life and patient treatment satisfaction in severe acne.
    Brodell RT; Schlosser BJ; Rafal E; Toth D; Tyring S; Wertheimer A; Kerrouche N; Bucher D
    J Dermatolog Treat; 2012 Feb; 23(1):26-34. PubMed ID: 22103674
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Adapalene/benzoyl peroxide gel 0.3%/2.5% for acne vulgaris.
    Dréno B; Layton AM; Troielli P; Rocha M; Chavda R
    Eur J Dermatol; 2022 Jul; 32(4):445-450. PubMed ID: 36301750
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Treatment of moderate to severe acne vulgaris in a Hispanic population: a post-hoc analysis of efficacy and tolerability of clindamycin phosphate 1.2%/benzoyl peroxide 2.5% gel.
    Cook-Bolden FE
    J Drugs Dermatol; 2012 Apr; 11(4):455-9. PubMed ID: 22453581
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Fixed Combination of Clindamycin Phosphate 1.2% and Benzoyl Peroxide 3.75% Aqueous Gel: Long-Term Use in Adult Females With Moderate Acne Vulgaris.
    Kircik LH
    J Drugs Dermatol; 2017 Jun; 16(6):543-546. PubMed ID: 28686771
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Is switching retinoids a sound strategy for the treatment of acne vulgaris?
    Gold LS; Colón LE; Johnson LA; Gottschalk RW
    J Drugs Dermatol; 2008 Jun; 7(6 Suppl):s11-7. PubMed ID: 18575221
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Prospective, open-label, comparative study of clindamycin 1%/benzoyl peroxide 5% gel with adapalene 0.1% gel in Asian acne patients: efficacy and tolerability.
    Ko HC; Song M; Seo SH; Oh CK; Kwon KS; Kim MB
    J Eur Acad Dermatol Venereol; 2009 Mar; 23(3):245-50. PubMed ID: 19438817
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Twelve-week, multicenter, placebo-controlled, randomized, double-blind, parallel-group, comparative phase II/III study of benzoyl peroxide gel in patients with acne vulgaris: A secondary publication.
    Kawashima M; Sato S; Furukawa F; Matsunaga K; Akamatsu H; Igarashi A; Tsunemi Y; Hayashi N; Yamamoto Y; Nagare T; Katsuramaki T
    J Dermatol; 2017 Jul; 44(7):774-782. PubMed ID: 28295516
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.